<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Tube Investments of India Limited

NSE: TIINDIA · Lot size: 200

Tube Investments of India Limited Open Interest & PCR Analysis

2,917Updated 21 Apr 2026, 01:26 pm IST
PCR
0.43
Bearish signal
Max Pain
2,660
Spot above by ₹257
Total CE OI
552K
Call writers
Total PE OI
238K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-18

Frequently Asked Questions

What is Tube Investments of India Limited PCR (Put-Call Ratio) today?
Tube Investments of India Limited's current PCR is 0.43. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Tube Investments of India Limited's PCR of 0.43 indicates bearish sentiment.
What is Tube Investments of India Limited OI buildup type today?
Tube Investments of India Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Tube Investments of India Limited?
Tube Investments of India Limited has total CE (call) OI of 551600 contracts and total PE (put) OI of 238000 contracts for the nearest expiry. The PCR is 0.43.
How is open interest analysis useful for Tube Investments of India Limited trading?
OI analysis for Tube Investments of India Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Tube Investments of India Limited?
Tube Investments of India Limited's max pain is ₹2,660 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.